All In Biotech

Drug Trial Radar · NCT06143631

Prescription of Letrozole for Uterine Myoma

Letrozole for Treatment of Uterine Fibroids: A Randomized, Placebo-Controlled Trial

Last checked: Nov 20, 2026Latest source record: Oct 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 140 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

140

Planned (sponsor's estimate)

Start

Jul 24, 2024

Primary completion

Sep 11, 2028

Study completion Dec 11, 2028

Sponsor

Lead sponsor
University of California, San FranciscoAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
First posted
Nov 22, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 21 years, up to 53 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The PLUM Study is a randomized, double-blinded, 2-arm, parallel-group, placebo-controlled trial is designed to compare the efficacy of letrozole versus placebo on leiomyoma-related symptoms and quality of life as well as leiomyoma and uterine size.

Conditions

  • Leiomyoma, Uterine
  • Leiomyoma
  • Fibroid
  • Fibroid Uterus

Interventions

  • Letrozole 2.5mgDrug

    Oral letrozole 2.5mg/day

  • PlaceboOther

    Placebo capsule

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Uterine leiomyoma-related symptom severity over 12 weeks of treatmentTime frame: Baseline to 12 weeks

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • University of California, Los Angeles

    Los Angeles, California · Recruiting

  • University of California, San Francisco

    San Francisco, California · Recruiting

  • Mayo Clinic

    Rochester, Minnesota · Recruiting

  • University of Mississippi Medical Center

    Jackson, Mississippi · Recruiting

  • Duke University

    Durham, North Carolina · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.